EMBL Australia

An $857,000 grant will enable critical research in tissue regeneration to be conducted by a multidisciplinary team, led by EMBL Australia and ARMI’s Professor Peter Currie and Associate Professor Mikaël Martino and Dr Ryan Hicks from AstraZeneca.

EMBL Australia group leader Associate Professor Mikaël Martino has been awarded a coveted Senior Medical Research Fellowship from the Sylvia and Charles Viertel Charitable Foundation to develop novel regenerative medicine technologies.

Genes in the human genome are made of DNA. Upon gene expression, a segment of DNA is copied into another molecule called RNA. When gene regulation goes wrong, diseases like cancer can occur. Therefore, knowing how enzymes — highly efficient protein nanomachines — work to switch genes on and off enables the development of new drugs and diagnostics.

News this quarter:

• Lights out for Parkinson’s disease
• Major Cancer Council grant for Dr Weatheritt
• Discovery may help boost peptide design
• Professor David Lynn talks everything COVID vaccines
• 2021 EMBL Australia PhD Course applications
• 2021 EMBL Australia Postgraduate Symposium registrations now open
• 2020 Highlights report now available

And more:

• Job opportunities
• Student opportunities
• Upcoming events
• Recent publications

Associate Professor Maté Biro is the Cell Motility and Mechanobiology Group Leader for EMBL Australia, based at the University of New South Wales.

Research led by EMBL Australia group leader Max Cryle has revealed a key aspect of peptide machineries, advancing his work in countering the global threat of antimicrobial resistance and having broad implications for health and industry.

Research led by EMBL Australia group leader Dr Harald Janovjak has revealed the potential of optogenetics - a relatively new and rapidly evolving technology - to treat Parkinson's disease.

News this quarter:

• A tribute to Scientia Professor Katharina Gaus FAHMS
• Reversing severe muscle wasting in disease, ageing & trauma
• Hint as to how SARS-CoV-2 might subvert immune defences
• Enabling the early and accurate diagnosis of Parkinson’s disease
• More than $4.8m awarded to EMBL Australia researchers in NHMRC Ideas Grants
• This protein empowers cancer cells – targeting it could kickstart new therapies
• Professor Ian Smith to chair the EMBL Australia Council
• Innovative research takes us one step closer to developing an effective malaria vaccine
• Did you know you can access EMBL’s cutting-edge scientific services?
• Get to know: Dr Vaishnavi Ananthanarayanan

 

And more:

• Job opportunities
• Upcoming events
• Recent publications

Dr Vaishnavi Ananthanarayanan recently joined EMBL Australia as a Group Leader, based at UNSW's Single Molecule Science.

Farewell to world-leading immunologist and molecular microscopist Scientia Professor Katharina Gaus - a visionary scientist, inspirational mentor, and much-loved friend, colleague and collaborator.